Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the cobas 4800 HPV test

Anticancer Research

Volumn 37, Issue 8, 2017, Pages 4183-4187

  Asciutto, Katrin Christine ^a   Henningsson, Anna J ^b   Borgfeldt, Henrik ^c   Darlin, Lotten ^a   Borgfeldt, Christer ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cytology; HPV analysis; Self collected vaginal smear; Vaginal smear

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA IN SITU; ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CERVICOVAGINAL SELF-SAMPLING DEVICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAMPLER; SELF CARE; SENSITIVITY AND SPECIFICITY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; URINE SAMPLING; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CYTOLOGY; VAGINA; VIRUS DETECTION; COLPOSCOPY; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PREGNANCY; PROCEDURES; URINE; UTERINE CERVIX CARCINOMA IN SITU; VAGINA SMEAR; VIROLOGY;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREGNANCY; VAGINA; VAGINAL SMEARS;

EID: 85026256356     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11807     Document Type: Article

References (16)

1. Darlin L, Borgfeldt C, Widen E and Kannisto P: Elderly women above screening age diagnosed with cervical cancer have a worse prognosis. Anticancer Res 34(9): 5147-5151, 2014.
2. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P and Anttila A: Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 15(2): 172-183, 2014.
3. Burroni E, Bonanni P, Sani C, Lastrucci V, Carozzi F, Hpv ScreeVacc Working G, Iossa A, Andersson KL, Brandigi L, Di Pierro C, Confortini M, Levi M, Boccalini S, Indiani L, Sala A, Tanini T, Bechini A and Azzari C: Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening. J Med Virol 87(3): 508-515, 2015.
4. Ducancelle A, Legrand MC, Pivert A, Veillon P, Le Guillou-Guillemette H and De Brux MA, Beby-Defaux A, Agius G, Hantz S, Alain S, Catala L, Descamps P, Postec E, Caly H, Charles-Petillon F, Labrousse F, Lunel F and Payan C: Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions. Arch Gynecol Obstet 290(2): 299-308, 2014.
5. Enerly E, Olofsson C and Nygard M: Monitoring human papillomavirus prevalence in urine samples: a review. Clin Epidemiol 5: 67-79, 2013.
6. Nicolau P, Mancebo G, Agramunt S, Sole-Sedeno JM and Bellosillo B, Muset MM, Lloveras B, Alameda F and Carreras R: Urine human papillomavirus prevalence in women with highgrade cervical lesions. Eur J Obstet Gynecol Reprod Biol 183: 12-15, 2014.
7. Pathak N, Dodds J, Zamora J and Khan K: Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ 349: g5264, 2014.
8. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wilkinson EJ, Zaino RJ, Wilbur DC, Members of LPWG: The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Lower Genital Tract Dis 16(3): 205-242, 2012.
9. Combita AL, Gheit T, Gonzalez P, Puerto D, Murillo RH, Montoya L, Vorsters A, Van Keer S, Van Damme P, Tommasino M, Hernandez-Suarez G and Sanchez L, Herrero R and Wiesner C: Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia. Cancer Prev Res 9(9): 766-771, 2016.
10. Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, Martin Mazuelos E: Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. J Clin Virol 61(4): 548-552, 2014.
11. Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A and Arbyn M: Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study). BMJ Open 6(4): e010660, 2016.
12. Franceschi S, Chantal Umulisa M, Tshomo U, Gheit T, Baussano I, Tenet V, Tshokey T, Gatera M, Ngabo F, Van Damme P, Snijders PJ, Tommasino M, Vorsters A and Clifford GM: Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda. Int J Cancer 139(3): 518-526, 2016.
13. Enerly E, Bonde J, Schee K, Pedersen H, Lonnberg S and Nygard M: Self-Sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian Cervical Cancer Screening Programme. PloS One 11(4): e0151978, 2016.
14. Darlin L, Borgfeldt C, Forslund O, Henic E, Hortlund M, Dillner J and Kannisto P: Comparison of use of vaginal HPV selfsampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol 58(1): 155-160, 2013.
15. Harper DM, Longacre MR, Noll WW, Belloni DR and Cole BF: Factors affecting the detection rate of human papillomavirus. Ann Fam Med 1(4): 221-227, 2003.
16. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosuppression and Cancer Study Group: Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 43(14): 2117-2123, 2007.